Nanotechnologies fundamentally change the current therapies and enable development of novel treatments and diagnostic approaches. The improvements in medical therapies and diagnostics achieved through innovative medical nanoproducts have a significant and direct clinical impact and provide benefits for the patients. Hence, best practices in design and development of such nanoproducts will contribute to societal prosperity and welfare, by providing access to safer and more effective treatments.
This meeting aims to strengthen relations between industry, R&D&I sector, regulatory agencies, clinics, and patients with the ultimate goal of fostering the clinical translation of nanomedicine from bench to bedside. By promoting scientific exchanges, technological implementation and innovative solutions, the meeting will enable dialogue for rationalizing and focusing research efforts at the EU level in dealing with the challenge of nanomedicine translation for cancer therapies.
There is no registration fee for this event but the number of attendees is limited. Please register by 20 February 2023.
Školska Knjiga d.d. (Main Aula)